{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:47Z","timestamp":1786119407030,"version":"build-2736575974"},"reference-count":5,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/wnf.0b013e3181dca95e","type":"journal-article","created":{"date-parts":[[2010,4,8]],"date-time":"2010-04-08T02:53:47Z","timestamp":1270695227000},"page":"212-213","source":"Crossref","is-referenced-by-count":3,"title":["Effectiveness and Safety of Milnacipran Treatment for a Patient With Delusional Disorder, Somatic Type Taking Multiple Medications for Concomitant Physical Diseases"],"prefix":"10.1097","volume":"33","author":[{"given":"Koichi","family":"Otani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Miura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihito","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osami","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"suppl 2","key":"R1-11-20210203","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1192\/S0007125000298978","article-title":"Monosymptomatic hypochondriacal psychosis.","volume":"153","author":"Munro","year":"1988","journal-title":"Br J Psychiatry"},{"key":"R3-11-20210203","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00004850-199905002-00006","article-title":"Clomipramine treatment of delusional disorder, somatic type.","volume":"14","author":"Wada","year":"1999","journal-title":"Int Clin Psychopharmacol"},{"key":"R4-11-20210203","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/hup.590","article-title":"Paroxetine treatment of delusional disorder, somatic type.","volume":"19","author":"Hayashi","year":"2004","journal-title":"Hum Psychopharmacol"},{"key":"R5-11-20210203","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/WNF.0b013e3181c1cfe4","article-title":"Successful treatment by paroxetine of delusional disorder, somatic type accompanied by severe secondary depression.","volume":"33","author":"Hayashi","year":"2010","journal-title":"Clin Neuropharmacol"},{"issue":"suppl 1","key":"R7-11-20210203","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/00004850-200206001-00004","article-title":"Pharmacology and pharmacokinetics of milnacipran.","volume":"17","author":"Puozzo","year":"2002","journal-title":"Int Clin Psychopharmacol"}],"container-title":["Clinical Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00002826-201007000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:13:32Z","timestamp":1786040012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00002826-201007000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/wnf.0b013e3181dca95e","relation":{},"ISSN":["0362-5664"],"issn-type":[{"value":"0362-5664","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}